Wells Fargo
AEON.WS

Wells Fargo’s AEON Biopharma Inc AEON.WS Stock Holding History

Wells Fargo’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-94,674
Closed -$8.52K – 7719
2023
Q2 		$8.52K Hold
94,674
– – ﹤0.01% 5945
2023
Q1 		$5.21K Hold
94,674
– – ﹤0.01% 6045
2022
Q4 		$4.32K Hold
94,674
– – ﹤0.01% 5818
2022
Q3 		$6K Hold
94,674
– – ﹤0.01% 5874
2022
Q2 		$14K Hold
94,674
– – ﹤0.01% 5625
2022
Q1 		$28K Hold
94,674
– – ﹤0.01% 5895
2021
Q4 		$48K Hold
94,674
– – ﹤0.01% 5986
2021
Q3 		$52K Hold
94,674
– – ﹤0.01% 5612
2021
Q2 		$90K Buy
+94,674
New +$71.9K ﹤0.01% 5331

Other funds holding AEON.WS

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wells Fargo's AEON.WS Position: Q3 2023 in Review

Wells Fargo sold out of AEON Biopharma Inc (AEON.WS) in Q3 2023, closing a stake of 94,674 shares — an estimated $8.52K sold.

Wells Fargo first reported a position in AEON.WS in Q2 2021 and held it in 9 quarters. The position peaked at $90K in Q2 2021. 40 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2023.

  • Wells Fargo reported no remaining AEON Biopharma Inc position as of Q3 2023 after selling out during the quarter.
  • Wells Fargo sold 94,674 AEON Biopharma Inc shares in Q3 2023, an estimated $8.52K.
  • Wells Fargo first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 9 quarters.
  • Wells Fargo's AEON Biopharma Inc position peaked at $90K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.